EyePoint Pharmaceuticals Inc (EYPT) Stock at a key inflection point
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
The growth of EyePoint Pharmaceuticals Inc (EYPT) Stock is expected to continue
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Stock Price Advanced 3.65% to $16.75
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
EyePoint Pharmaceuticals Inc (EYPT) Stock creates opportunities due to its volume and complexity
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
Getting Ready for the Bounce: EyePoint Pharmaceuticals Inc (EYPT) Stock
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
Are there any attempts to gain ground? EyePoint Pharmaceuticals Inc (EYPT) Stock
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock Market Value Reached at $1.03 billion: What Happened?
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
A Real Picture of EyePoint Pharmaceuticals Inc (EYPT) Stock: The Fundamentals
JP Morgan raised the price target for the EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) stock to “an Overweight”. The rating was released on January 22, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $33. The stock was initiated by Chardan Capital Markets, […]
